- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Penfluridol overcomes paclitaxel resistance in metastatic breast cancer ; volume:9 ; number:1 ; day:25 ; month:3 ; year:2019 ; pages:1-14 ; date:12.2019
Scientific reports ; 9, Heft 1 (25.3.2019), 1-14, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Gupta, Nehal
Gupta, Parul
Srivastava, Sanjay K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-41632-0
- URN
-
urn:nbn:de:101:1-2019041200374712311085
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gupta, Nehal
- Gupta, Parul
- Srivastava, Sanjay K.
- SpringerLink (Online service)
Other Objects (12)
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer
PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Breast cancer nab-Paclitaxel
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer
PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Breast cancer nab-Paclitaxel
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer
PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Breast cancer nab-Paclitaxel
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer